News and stories

Who are Kitea Health?

Who are Alimetry?

Who are Wellumio?

At a glance Previously focussed on animal probiotics, a meeting with Callaghan Innovation at Fieldays® opened the way for BioBrew to move into human health supplements.

At a glance Saflex Pumps had already developed chemical dispensing equipment for the dairy industry.

At a glance Biotech startup Amaroq Therapeutics is developing therapies to fight some of the most hard-to-treat and prevalent cancers.

At a glance Helico is aiming to produce therapeutic compounds from plants and, ultimately, ‘edible medicine’, with the technology potentially increasing accessibility and affordability of essential medicines.

At a glance After being granted New Zealand’s first GMP licence, Helius Therapeutics got the green light to manufacture medical cannabis products in a bid to bring the first locally-made products to market.

Callaghan Innovation has launched a HealthTech Activator (HTA) to support commercialisation in New Zealand’s healthtech sector, which generated an estimated $2.85 billion revenue last financial year, with many healthtech companies achieving record growth since COVID-19 struck.

At a glance With a growing resistance to antibiotics for infections, Manuka Bioscience has been exploring using oil from East Cape mānuka trees to develop treatments for skin infections.

At a glance Healthtech startup HeartLab is using artificial intelligence (AI) to help in the fight against heart disease, helping doctors with the time-consuming and manual process of reviewing echocardiograms. HeartLab has tapped into New Zealand’s healthtech ecosystem, including accessing Callaghan Innovation support, to help it with everything from company incubation, to funding, to market validation.

At a glance Christchurch-based See-LEVEL has developed a virtual reality solution to alleviate seasickness.